This site is intended for healthcare professionals only
LoginRegister

Oncology Dialogues

Bayer, Kumquat Biosciences ink pact to develop, commercialize KRAS G12D inhibitor

Bayer, Kumquat Biosciences ink pact to develop, commercialize KRAS G12D inhibitor

Berlin: Bayer and Kumquat Biosciences Inc., a clinical-stage biotech company, have announced that they have entered into an exclusive global...
View All

Latest News and Guidelines

Virchow Biotech Gets CDSCO Panel Nod for Semaglutide BE, Phase III Trials

New-Onset Diabetes Strongly Linked to Increased Short-Term Risk of Pancreatic Cancer: Study

Assam doctor develops low cost, eco freindly, safe breast self examination model, wins design patent

When should preventive mastectomy be offered for women at higher risk of breast cancer?

Gene-based blood test for melanoma may predict recurrence, reveals research

Gene-based blood test for melanoma may predict recurrence, reveals research

Patients own autoantibodies may hold key to boosting cancer immunotherapy response, reveals research

Patients' own autoantibodies may hold key to boosting cancer immunotherapy response, reveals...

FDA Grants Accelerated Approval to Zongertinib for HER2-Mutated NSCLC

FDA Grants Accelerated Approval to Zongertinib for HER2-Mutated NSCLC

cancer

Tumor diagnostics: AI model detects more than 170 types of cancer

View All
X